Literature DB >> 15562129

Trends in cardiovascular complications of diabetes.

Caroline S Fox1, Sean Coady, Paul D Sorlie, Daniel Levy, James B Meigs, Ralph B D'Agostino, Peter W F Wilson, Peter J Savage.   

Abstract

CONTEXT: Despite reductions in cardiovascular disease (CVD) mortality over the past few decades, it is unclear whether adults with and without diabetes have experienced similar declines in CVD risk.
OBJECTIVE: To determine whether adults with and without diabetes experienced similar declines in incident CVD in 1950-1995. DESIGN, SETTING, AND PARTICIPANTS: Participants aged 45-64 years from the Framingham Heart Study original and offspring cohorts who attended examinations in 1950-1966 ("earlier" time period; 4118 participants, 113 with diabetes) and 1977-1995 ("later" time period; 4063 participants, 317 with diabetes). Incidence rates of CVD among those with and without diabetes were compared between the earlier and later periods. MAIN OUTCOME MEASURES: Myocardial infarction, coronary heart disease death, and stroke.
RESULTS: Among participants with diabetes, the age- and sex-adjusted CVD incidence rate was 286.4 per 10,000 person-years in the earlier period and 146.9 per 10,000 in the later period, a 49.3% (95% confidence interval [CI], 16.7%-69.4%) decline. Among participants without diabetes, the age- and sex-adjusted incidence rate was 84.6 per 10,000 person-years in the earlier period and 54.3 per 10,000 person-years in the later period, a 35.4% (95% CI, 25.3%-45.4%) decline. Hazard ratios for diabetes as a predictor of incident CVD were not different in the earlier vs later periods.
CONCLUSIONS: We report a 50% reduction in the rate of incident CVD events among adults with diabetes, although the absolute risk of CVD is 2-fold greater than among persons without diabetes. Adults with and without diabetes have benefited similarly during the decline in CVD rates over the last several decades. More aggressive treatment of CVD risk factors and further research on diabetes-specific factors contributing to CVD risk are needed to further reduce the high absolute risk of CVD still experienced by persons with diabetes.

Entities:  

Mesh:

Year:  2004        PMID: 15562129     DOI: 10.1001/jama.292.20.2495

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  171 in total

1.  Low Plasma Hdl Cholesterol and Elevated C Reactive Protein further Increase Cardiovascular Disease Risk in Latinos with Type 2 Diabetes.

Authors:  Mariana C Calle; Sonia Vega-López; Sofia Segura-Pérez; Jeff S Volek; Rafael Pérez-Escamilla; Maria Luz Fernandez
Journal:  J Diabetes Metab       Date:  2010-11-10

2.  Heart disease and stroke statistics--2012 update: a report from the American Heart Association.

Authors:  Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Emelia J Benjamin; Jarett D Berry; William B Borden; Dawn M Bravata; Shifan Dai; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Elsayed Z Soliman; Paul D Sorlie; Nona Sotoodehnia; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2011-12-15       Impact factor: 29.690

3.  Heart disease and stroke statistics--2011 update: a report from the American Heart Association.

Authors:  Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Robert J Adams; Jarett D Berry; Todd M Brown; Mercedes R Carnethon; Shifan Dai; Giovanni de Simone; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Kurt J Greenlund; Susan M Hailpern; John A Heit; P Michael Ho; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Mary M McDermott; James B Meigs; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Wayne D Rosamond; Paul D Sorlie; Randall S Stafford; Tanya N Turan; Melanie B Turner; Nathan D Wong; Judith Wylie-Rosett
Journal:  Circulation       Date:  2010-12-15       Impact factor: 29.690

Review 4.  The Framingham Heart Study--67 years of discovery in metabolic disease.

Authors:  Michelle T Long; Caroline S Fox
Journal:  Nat Rev Endocrinol       Date:  2016-01-18       Impact factor: 43.330

Review 5.  Polychlorinated biphenyls and links to cardiovascular disease.

Authors:  Jordan T Perkins; Michael C Petriello; Bradley J Newsome; Bernhard Hennig
Journal:  Environ Sci Pollut Res Int       Date:  2015-04-17       Impact factor: 4.223

6.  Change in chronic disability from 1982 to 2004/2005 as measured by long-term changes in function and health in the U.S. elderly population.

Authors:  Kenneth G Manton; XiLiang Gu; Vicki L Lamb
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-13       Impact factor: 11.205

7.  Temporal trends in the use of antidiabetic medicines: a nationwide 9-year study in older people living in New Zealand.

Authors:  Prasad S Nishtala; Mohammed Saji Salahudeen
Journal:  Ther Adv Drug Saf       Date:  2016-07-21

8.  Socioeconomic position and cardiovascular disease in adults with and without diabetes: United States trends, 1997-2005.

Authors:  Rosemary Dray-Spira; Tiffany L Gary; Frederick L Brancati
Journal:  J Gen Intern Med       Date:  2008-07-31       Impact factor: 5.128

9.  The burden of diabetes-related mortality in France in 2002: an analysis using both underlying and multiple causes of death.

Authors:  Isabelle Romon; Eric Jougla; Beverley Balkau; Anne Fagot-Campagna
Journal:  Eur J Epidemiol       Date:  2008       Impact factor: 8.082

10.  Flow patterns regulate hyperglycemia-induced subendothelial matrix remodeling during early atherogenesis.

Authors:  Jonette Green; Arif Yurdagul; Marshall C McInnis; Patrick Albert; A Wayne Orr
Journal:  Atherosclerosis       Date:  2013-12-08       Impact factor: 5.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.